Skip to main content
    • Aa
    • Aa
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 1
  • Cited by
    This article has been cited by the following publications. This list is generated based on data provided by CrossRef.

    Mansour, E. Loxton, C. Elias, R.M. and Ormondroyd, G.A. 2014. Assessment of health implications related to processing and use of natural wool insulation products. Environment International, Vol. 73, p. 402.


B. anthracis in a wool-processing factory: seroprevalence and occupational risk

  • E. KISSLING (a1) (a2), P. WATTIAU (a3), B. CHINA (a1), M. PONCIN (a4), D. FRETIN (a3), Y. PIRENNE (a5) and G. HANQUET (a1) (a6)
  • DOI:
  • Published online: 11 August 2011

In a Belgian wool-processing factory, living anthrax spores were found in raw goat hair and air dust, but confirmed anthrax cases had never been reported. Anthrax vaccines are not licensed nor recommended in Belgium. We conducted a B. anthracis seroprevalence study to investigate risk factors associated with positive serology and advise on protective measures. Overall 12·1% (8/66) employees were seropositive; 30% of persons processing raw goat hair and 20% of persons sorting raw goat hair were seropositive compared to 3% in less exposed jobs [adjusted prevalence ratio (aPR) 44·4, P=0·001; aPR 14·5, P=0·016, respectively). The number of masks used per day was protective (aPR 0·3, P=0·015). Results suggest a dose–response association for those processing raw goat hair. Host-related factors probably played a role as antibody response varied from person to person within an exposure group. Workers exposed to raw goat hair should be offered higher protection against anthrax and have access to anthrax vaccines.

Corresponding author
*Author for correspondence: E. Kissling, 33 Chestnut Avenue, Esher, Surrey KT10 8JF, UK. (Email:
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

1.PK Dewan , Inhalational anthrax outbreak among postal workers, Washington, DC, 2001. Emerging Infectious Diseases 2002; 8: 10661072.

2.JH Bell , E Fee , TM Brown . Anthrax and the wool trade. 1902. American Journal of Public Health 2002; 92: 754757.

3.PS Brachman , FR Fekety . Industrial anthrax. Annals of the New York Academy of Sciences 1958; 70: 574584.

4.ME Bales , Epidemiologic response to anthrax outbreaks: field investigations, 1950–2001. Emerging Infectious Diseases 2002; 8: 11631174.

7.N Metcalfe . The history of woolsorters' disease: a Yorkshire beginning with an international future? Occupational Medicine 2004; 54: 489493.

9.S Anaraki , Investigations and control measures following a case of inhalation anthrax in East London in a drum maker and drummer, October 2008. Eurosurveillance 2008; 13.

12.DL Doolan , The US capitol bioterrorism anthrax exposures: clinical epidemiological and immunological characteristics. Journal of Infectious Diseases 2007; 195: 174184.

13.P Wattiau , Occurrence and genetic diversity of Bacillus anthracis strains isolated in an active wool-cleaning factory. Applied and Environmental Microbiology 2008; 74: 40054011.

14.P Wattiau , Immunologic response of unvaccinated workers exposed to anthrax, Belgium. Emerging Infectious Diseases 2009; 15: 16371640.

15.RE Biagini , Determination of serum IgG antibodies to Bacillus anthracis protective antigen in environmental sampling workers using a fluorescent covalent microsphere immunoassay. Occupational and Environmental Medicine 2004; 61: 703708.

16.JL Hadler . Learning from the 2001 anthrax attacks: immunological characteristics. The Journal of Infectious Diseases 2007; 195: 163164.

18.KP Fennelly , Airborne infection with Bacillus anthracis – from mills to mail. Emerging Infectious Diseases 2004; 10: 996–1002.

20.WT Sanderson , Bacillus anthracis contamination and inhalational anthrax in a mail processing and distribution center. Journal of Applied Microbiology 2004; 96: 10481056.

21.R Grunow , Monitoring of ELISA-reactive antibodies against anthrax protective antigen (PA), lethal factor (LF), and toxin-neutralising antibodies in serum of individuals vaccinated against anthrax with the PA-based UK anthrax vaccine. Vaccine 2007; 25: 36793683.

22.CP Quinn , Immune responses to Bacillus anthracis protective antigen in patients with bioterrorism-related cutaneous or inhalation anthrax. Journal of Infectious Diseases 2004; 190: 12281236.

23.N Abboud , A Casadevall . Immunogenicity of Bacillus anthracis protective antigen domains and efficacy of elicited antibody responses depend on host genetic background. Clinical and Vaccine Immunology 2008; 15: 11151123.

24.MN Swartz . Recognition and management of anthrax – an update. New England Journal of Medicine 2001; 345: 16211626.

25.E Van den Enden , A Van Gompel , M Van Esbroeck . Cutaneous anthrax, Belgian traveler. Emerging Infectious Diseases 2006; 12: 523525.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Epidemiology & Infection
  • ISSN: 0950-2688
  • EISSN: 1469-4409
  • URL: /core/journals/epidemiology-and-infection
Please enter your name
Please enter a valid email address
Who would you like to send this to? *